Kelland LR - Search Results

1

High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance.

Cocker HA, Hobbs SM, Tiffin N, Pritchard-Jones K, Pinkerton CR, Kelland LR. Cocker HA, et al. Among authors: kelland lr. Br J Cancer. 2001 Nov 30;85(11):1746-52. doi: 10.1054/bjoc.2001.2145. Br J Cancer. 2001. PMID: 11742497 Free PMC article.

2

Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.

Sharp SY, Smith V, Hobbs S, Kelland LR. Sharp SY, et al. Among authors: kelland lr. Br J Cancer. 1998 Jul;78(2):175-80. doi: 10.1038/bjc.1998.461. Br J Cancer. 1998. PMID: 9683290 Free PMC article.

3

Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.

Cocker HA, Pinkerton CR, Kelland LR. Cocker HA, et al. Among authors: kelland lr. Br J Cancer. 2000 Aug;83(3):338-45. doi: 10.1054/bjoc.2000.1273. Br J Cancer. 2000. PMID: 10917549 Free PMC article.

4

In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.

Cocker HA, Tiffin N, Pritchard-Jones K, Pinkerton CR, Kelland LR. Cocker HA, et al. Among authors: kelland lr. Clin Cancer Res. 2001 Oct;7(10):3193-8. Clin Cancer Res. 2001. PMID: 11595714

5

Effect of p53 status on sensitivity to platinum complexes in a human ovarian cancer cell line.

Pestell KE, Hobbs SM, Titley JC, Kelland LR, Walton MI. Pestell KE, et al. Among authors: kelland lr. Mol Pharmacol. 2000 Mar;57(3):503-11. doi: 10.1124/mol.57.3.503. Mol Pharmacol. 2000. PMID: 10692490

6

Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo.

Rogers PM, Beale PJ, Al-Moundhri M, Boxall F, Patterson L, Valenti M, Raynaud F, Hobbs S, Johnston S, Kelland LR. Rogers PM, et al. Among authors: kelland lr. Int J Cancer. 2002 Feb 20;97(6):858-63. doi: 10.1002/ijc.10132. Int J Cancer. 2002. PMID: 11857368

7

Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo.

Sharp SY, Kelland LR, Valenti MR, Brunton LA, Hobbs S, Workman P. Sharp SY, et al. Among authors: kelland lr. Mol Pharmacol. 2000 Nov;58(5):1146-55. doi: 10.1124/mol.58.5.1146. Mol Pharmacol. 2000. PMID: 11040064

8

ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin.

Smith V, Hobbs S, Court W, Eccles S, Workman P, Kelland LR. Smith V, et al. Among authors: kelland lr. Anticancer Res. 2002 Jul-Aug;22(4):1993-9. Anticancer Res. 2002. PMID: 12174876

9

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.

Beale PJ, Rogers P, Boxall F, Sharp SY, Kelland LR. Beale PJ, et al. Among authors: kelland lr. Br J Cancer. 2000 Jan;82(2):436-40. doi: 10.1054/bjoc.1999.0939. Br J Cancer. 2000. PMID: 10646901 Free PMC article.

10

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.

Mellish KJ, Kelland LR, Harrap KR. Mellish KJ, et al. Among authors: kelland lr. Br J Cancer. 1993 Aug;68(2):240-50. doi: 10.1038/bjc.1993.322. Br J Cancer. 1993. PMID: 8347478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters